
    
      All subjects in these extension phases of the study were previously vaccinated with the
      investigational herpes zoster vaccine GSK1437173A. The Protocol Posting has been updated in
      order to comply with the FDA Amendment Act, Sep 2007.

      Further details on the primary study can be found on our GSK study register
      (https://www.gsk-studyregister.com/advanced-search) by searching on the GSK study identifier
      101501.
    
  